Phialogics
Biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation
Phialogics has raised €600k across 1 funding round from 1 investor, most recently a Pre-Seed round in Apr 2023. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€600k
€600,000
Funding rounds
1
Investors
1
distinct backers
Active since
2023-04
latest 2023-04
Funding by year
EUR raised per yearPhialogics — funding by year — interactive chart.
Data table
| Phialogics — funding by year | |
|---|---|
| 2023 | €600k |
Signals
High confidenceRaise-next likelihood5
base rate 24% for Pre-Seed
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-19 | Pre-Seed | €600k | High-Tech Gründerfonds (HTGF) | View deal → |
Investors
1Related news
- Phialogics closes 600,000 € pre-seed financing roundstartupticker.ch · 2023-04
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData